gilead is pretty stacked on the treatment panel. wonder why Rem was chosen. weird.Appendix A, Table 2. COVID-19 Treatment Guidelines Panel Financial Disclosure for Companies Related to COVID-19 Treatment or Diagnostics
Last Updated: June 11, 2020
Reporting Period: May 1, 2019, to March 31, 2020
https://www.covid19treatmentguidelines.nih.gov/panel-financial-disclosure/
Member Financial Disclosure Company Relationship Judith Aberg, MD Gilead Sciences Research Support Regeneron Research Support Adaora Adimora, MD, MPH Gilead Sciences Consultant, Research Support Jason Baker, MD, MS Gilead Science Research Support Lisa Baumann Kreuziger, MD, MS 3M Stockholder, spouse is an employee CSL Behring Advisory Board for Non-Approved Medications Quercegen Pharmaceuticals Advisory Board for Non-Approved Medications Versiti Employee Roger Bedimo, MD, MS Gilead Sciences Honoraria Pamela S. Belperio, PharmD None N/A Laura Bosque Ortiz, BS None N/A John T. Brooks, MD None N/A Timothy Burges, MD None N/A Stephen V. Cantrill, MD None N/A Ann C. Collier, MD None N/A Craig Coopersmith, MD None N/A Page Crew, PharmD, MPH None N/A Eric Daar, MD Gilead Sciences Consultant, Research Support Richard T. Davey, Jr., MD None N/A Susan L. Davis, PharmD None N/A Laurie K. Doepel, BA None N/A Amy L. Dzierba, PharmD None N/A Robert W. Eisinger, PhD None N/A Laura Evans, MD, MSc None N/A Joseph Francis, MD, MPH None N/A Rajesh Gandhi, MD Merck & Co. Advisory Board David V. Glidden, PhD Gilead Sciences Consultant Birgit Grund, PhD None N/A Roy M. Gulick, MD, MPH None N/A Erica J. Hardy, MD, MMSc None N/A Elizabeth S. Higgs, MD, DTM&H, MIA None N/A Brenna L. Hughes, MD, MSc None N/A Steven Johnson, MD None N/A Marla J. Keller, MD None N/A Arthur Kim, MD None N/A Safia Kuriakose, PharmD None N/A H. Clifford Lane, MD None N/A Jeffrey L. Lennox, MD None N/A Andrea M. Lerner, MD, MS None N/A Mitchell M. Levy, MD None N/A Gregory Martin, MD, MSc Regeneron Consultant Henry Masur, MD None N/A Susanna Naggie, MD, MHS AbbVie Research Support Gilead Sciences Research Support Vir Biotechnology Advisory Board, Stockholder Martha C. Naso, PhD None N/A Alice K. Pau, PharmD None N/A Andrew T. Pavia, MD Genentech Consultant Merck & Co. Consultant Seqirus Consultant Nitin Seam, MD None N/A Virginia Sheikh, MD, MHS None N/A Steven Q. Simpson, MD None N/A Kanal Singh, MD, MPH None N/A Susan Swindells, MBBS None N/A Pablo Tebas, MD Gilead Sciences Research Support INOVIO Pharmaceuticals Research Support Phyllis Tien, MD, MSc None N/A Timothy M. Uyeki, MD, MPH None N/A Alpana A. Waghmare, MD Ansun BioPharma Research Support KYORIN Pharmaceutical Co. Advisory Board Robert Walker, MD None N/A Kevin C. Wilson, MD None N/A
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-4148
-
- There are more pages in this discussion • 13,676 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B |
Open | High | Low | Value | Volume |
$1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 99680 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 31000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 99680 | 1.150 |
2 | 17000 | 1.140 |
1 | 40000 | 1.125 |
5 | 158332 | 1.100 |
2 | 15000 | 1.095 |
Price($) | Vol. | No. |
---|---|---|
1.155 | 31000 | 2 |
1.160 | 27391 | 2 |
1.170 | 22300 | 2 |
1.175 | 26294 | 3 |
1.180 | 85298 | 3 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |